DOI:
10.1055/s-00034922
Arthritis und Rheuma
LinksClose Window
References
McInnes IB, Mease PJ, Ritchlin CT. et al.
Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study.
Rheumatology (Oxford) 2017;
56 (11) 1993-2003.
We do not assume any responsibility for the contents of the web pages of other providers.